+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Angiotensin-Converting Enzyme Converts Amyloid b-Protein 1-42 (Ab1 - 42 ) to Ab1 -40 and Its Inhibition Enhances Brain Ab Deposition



Angiotensin-Converting Enzyme Converts Amyloid b-Protein 1-42 (Ab1 - 42 ) to Ab1 -40 and Its Inhibition Enhances Brain Ab Deposition



Journal of Neuroscience 27(32): 28-35




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 017771263

Download citation: RISBibTeXText


Related references

Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition. Journal of Neuroscience 27(32): 8628-8635, 2007

Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation. Shock 43(4): 395-404, 2016

Regulation of Steady-state (Sb(B-Amyloid Levels in the Brain by Neprilysin and Endothelin-converting Enzyme but Not Angiotensin-converting Enzyme. Journal of biological chemistry13 281(41): 30471-30478, 2006

Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. Journal of Biological Chemistry 281(41): 30471-8, 2006

Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction. Journal of Cardiovascular Pharmacology 51(6): 565-572, 2008

Murine Recombinant Angiotensin-Converting Enzyme 2 Effect on Angiotensin II-Dependent Hypertension and Distinctive Angiotensin-Converting Enzyme 2 Inhibitor Characteristics on Rodent and Human Angiotensin-Converting Enzyme 2 Renin-Angiotensin-Aldosteron. 2012

Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats. American Journal of Hypertension 16(11 Pt 1): 931-937, 2003

Placebo-controlled, randomised, angiotensin converting enzyme inhibition, comparative trial in cardiac infarction and left ventricular function Benefits of immediate angiotensin converting enzyme inhibition Results of the practical study. European Heart Journal 14(ABSTR SUPPL ): 432, 1993

Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: Relationship to angiotensin-converting enzyme inhibition. European Journal of Clinical Pharmacology 46(5): 431-436, 1994

Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats. Journal of Biochemical and Molecular Toxicology 27(7): 378-387, 2013

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circulation Research 87(5): e1-e9, 2000